CompletedPhase 1NCT00004263

Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Studying C syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
M.D. Anderson Cancer Center
Principal Investigator
Jorge Cortes, MD
M.D. Anderson Cancer Center
Intervention
7-hydroxystaurosporine (UCN-01)(drug)
Enrollment
16 enrolled
Eligibility
All sexes
Timeline
19992007

Study locations (2)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00004263 on ClinicalTrials.gov

Other trials for C syndrome

Additional recruiting or active studies for the same condition.

See all trials for C syndrome

← Back to all trials